← All companies

PIII

P3 Health Partners Inc.

PIII Nasdaq Services-Health Services EDGAR ↗

$10.02

-0.20 -1.96%

Key statistics

from XBRL data in SEC filings

Market cap

$84.3M

Revenue (TTM)

$1.47B

Net income (TTM)

-$126M

EPS (TTM)

$-38.66

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$25.5M

Total assets

$674M

Gross margin

—

52-week range

$1.52 – $16.89

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement Jul 6, 2026 8-K Shareholder vote results Jun 10, 2026 8-K Delisting notice or listing-rule failure May 26, 2026 8-K Delisting notice or listing-rule failure; Other events May 15, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws Apr 28, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Entered a material agreement Mar 25, 2026 8-K Entered a material agreement Feb 17, 2026 8-K Delisting notice or listing-rule failure Nov 28, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Entered a material agreement Nov 14, 2025 8-K Entered a material agreement Aug 29, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Director or officer change Jul 9, 2025 8-K Shareholder vote results Jun 10, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 8-K Modified rights of security holders; Amended charter or bylaws Apr 17, 2025 8-K Other events Apr 4, 2025 8-K Shareholder vote results Apr 3, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Feb 18, 2025 8-K Regulation FD disclosure Feb 13, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity Dec 17, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Director or officer change Aug 29, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Shareholder vote results Jun 7, 2024 8-K Entered a material agreement; Unregistered sale of equity May 24, 2024 8-K Entered a material agreement; Unregistered sale of equity May 23, 2024 8-K Delisting notice or listing-rule failure May 20, 2024